BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for June 2018
The 6th annual Coffey-Holden Prostate Cancer Academy took place at UCLA from June 21st - 24th. This annual, invitation-only meeting sponsored by the Prostate Cancer Foundation is uniquely designed to...Read More
Back in January, we shared Len Bellavia’s story about his “new lease on life” after a mistaken diagnosis of advanced prostate cancer - what he called “the worst moment of...Read More
This Father’s Day, if you won’t do it for yourself, do it for your daughter. Dr. Mary-Claire King, a geneticist at the University of Washington, who is credited with discovering...Read More
Steve Malikowski, who has been diagnosed with metastatic prostate cancer, set out to cross the country on a bike in early May. It’s a total of 4,100 miles from coast...Read More